A business in context
NRIX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-25 | Ring Christine | S · Sale | Common Stock | 28935.0 | 20.06 |
| 2026-06-25 | Ring Christine | M · Exercise / conversion | Common Stock | 15602.0 | 8.72 |
| 2026-06-25 | Ring Christine | M · Exercise / conversion | Common Stock | 13333.0 | 7.26 |
| 2026-06-25 | Ring Christine | M · Exercise / conversion | Employee Stock Option (right to buy) | 13333.0 | 0.0 |
| 2026-06-25 | Ring Christine | M · Exercise / conversion | Employee Stock Option (right to buy) | 15602.0 | 0.0 |
| 2026-06-25 | Hansen Gwenn | S · Sale | Common Stock | 5394.0 | 20.0 |
| 2026-06-02 | Ring Christine | S · Sale | Common Stock | 8148.0 | 16.6 |
| 2026-06-02 | Ring Christine | M · Exercise / conversion | Common Stock | 3422.0 | 1.86 |
| 2026-06-02 | Ring Christine | M · Exercise / conversion | Employee Stock Option (right to buy) | 3422.0 | 0.0 |
| 2026-05-15 | Saltzman Edward C | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | DANSEY ROGER D | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | Lacey David L. | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | Kapur Anil | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | Baynes Roy D. | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | Silva Paul M | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | Reinsdorf Judith A | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-15 | GREGORY JULIA P | A · Grant / award | Director Stock Option (right to buy) | 31250.0 | 0.0 |
| 2026-05-05 | van Houte Hans | S · Sale | Common Stock | 582.0 | 17.18 |
| 2026-05-05 | van Houte Hans | S · Sale | Common Stock | 13473.0 | 16.58 |
| 2026-05-04 | Ring Christine | S · Sale | Common Stock | 8148.0 | 16.96 |
| 2026-05-01 | Ring Christine | S · Sale | Common Stock | 5394.0 | 16.76 |
| 2026-04-30 | van Houte Hans | S · Sale | Common Stock | 2388.0 | 16.65 |
| 2026-04-30 | van Houte Hans | M · Exercise / conversion | Common Stock | 2858.0 | 0.0 |
| 2026-04-30 | van Houte Hans | M · Exercise / conversion | Common Stock | 2000.0 | 0.0 |
| 2026-04-30 | van Houte Hans | M · Exercise / conversion | Common Stock | 3750.0 | 0.0 |
| 2026-04-30 | van Houte Hans | M · Exercise / conversion | Restricted Stock Units | 2858.0 | 0.0 |
| 2026-04-30 | van Houte Hans | M · Exercise / conversion | Restricted Stock Units | 3750.0 | 0.0 |
| 2026-04-30 | van Houte Hans | M · Exercise / conversion | Restricted Stock Units | 2000.0 | 0.0 |
| 2026-04-30 | Ring Christine | M · Exercise / conversion | Common Stock | 2000.0 | 0.0 |
| 2026-04-30 | Ring Christine | M · Exercise / conversion | Common Stock | 3750.0 | 0.0 |
| 2026-04-30 | Ring Christine | M · Exercise / conversion | Common Stock | 2858.0 | 0.0 |
| 2026-04-30 | Ring Christine | S · Sale | Common Stock | 3214.0 | 16.65 |
| 2026-04-30 | Ring Christine | M · Exercise / conversion | Restricted Stock Units | 3750.0 | 0.0 |
| 2026-04-30 | Ring Christine | M · Exercise / conversion | Restricted Stock Units | 2858.0 | 0.0 |
| 2026-04-30 | Ring Christine | M · Exercise / conversion | Restricted Stock Units | 2000.0 | 0.0 |
| 2026-04-30 | Hansen Gwenn | S · Sale | Common Stock | 3214.0 | 16.65 |
| 2026-04-30 | Hansen Gwenn | M · Exercise / conversion | Common Stock | 2858.0 | 0.0 |
| 2026-04-30 | Hansen Gwenn | M · Exercise / conversion | Common Stock | 2000.0 | 0.0 |
| 2026-04-30 | Hansen Gwenn | M · Exercise / conversion | Common Stock | 3750.0 | 0.0 |
| 2026-04-30 | Hansen Gwenn | M · Exercise / conversion | Restricted Stock Units | 2858.0 | 0.0 |
| 2026-04-30 | Hansen Gwenn | M · Exercise / conversion | Restricted Stock Units | 3750.0 | 0.0 |
| 2026-04-30 | Hansen Gwenn | M · Exercise / conversion | Restricted Stock Units | 2000.0 | 0.0 |
| 2026-04-02 | Ring Christine | S · Sale | Common Stock | 8148.0 | 15.24 |
Identity & relationships
SEC issuer · 0001549595Nurix Therapeutics, Inc.
Search names and former names
View Wikidata identity and references ↗
- Nurix (United States) · alias · wikidata
- Nurix, Inc. · former SEC name · 2012-05-15 to 2015-09-18
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-11-30 | $54.55M | $58.20M |
| 2023-11-30 | $76.99M | $84.60M |
| 2022-11-30 | $38.63M | $44.30M |